These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 26306650

  • 1. Supplementation of antipsychotic treatment with sarcosine – GlyT1 inhibitor – causes changes of glutamatergic (1)NMR spectroscopy parameters in the left hippocampus in patients with stable schizophrenia.
    Strzelecki D, Podgórski M, Kałużyńska O, Gawlik-Kotelnicka O, Stefańczyk L, Kotlicka-Antczak M, Gmitrowicz A, Grzelak P.
    Neurosci Lett; 2015 Oct 08; 606():7-12. PubMed ID: 26306650
    [Abstract] [Full Text] [Related]

  • 2. Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia.
    Strzelecki D, Podgórski M, Kałużyńska O, Gawlik-Kotelnicka O, Stefańczyk L, Kotlicka-Antczak M, Gmitrowicz A, Grzelak P.
    Nutrients; 2015 Oct 22; 7(10):8767-82. PubMed ID: 26506383
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of Metabolite Concentrations in the Left Dorsolateral Prefrontal Cortex, the Left Frontal White Matter, and the Left Hippocampus in Patients in Stable Schizophrenia Treated with Antipsychotics with or without Antidepressants. ¹H-NMR Spectroscopy Study.
    Strzelecki D, Grzelak P, Podgórski M, Kałużyńska O, Stefańczyk L, Kotlicka-Antczak M, Gmitrowicz A.
    Int J Mol Sci; 2015 Oct 15; 16(10):24387-402. PubMed ID: 26501256
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia.
    Lane HY, Huang CL, Wu PL, Liu YC, Chang YC, Lin PY, Chen PW, Tsai G.
    Biol Psychiatry; 2006 Sep 15; 60(6):645-9. PubMed ID: 16780811
    [Abstract] [Full Text] [Related]

  • 8. Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
    Yamasue H, Fukui T, Fukuda R, Kasai K, Iwanami A, Kato N, Kato T.
    Int J Neuropsychopharmacol; 2003 Dec 15; 6(4):353-60. PubMed ID: 14604450
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Whole-brain patterns of (1)H-magnetic resonance spectroscopy imaging in Alzheimer's disease and dementia with Lewy bodies.
    Su L, Blamire AM, Watson R, He J, Hayes L, O'Brien JT.
    Transl Psychiatry; 2016 Aug 30; 6(8):e877. PubMed ID: 27576166
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. (1)H-MRS of hippocampus in patients after first manic episode.
    Gigante AD, Lafer B, Yatham LN.
    World J Biol Psychiatry; 2014 Feb 30; 15(2):145-54. PubMed ID: 23984710
    [Abstract] [Full Text] [Related]

  • 14. Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS).
    Tayoshi S, Sumitani S, Taniguchi K, Shibuya-Tayoshi S, Numata S, Iga J, Nakataki M, Ueno S, Harada M, Ohmori T.
    Schizophr Res; 2009 Mar 30; 108(1-3):69-77. PubMed ID: 19097753
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample.
    Bustillo JR, Jones T, Chen H, Lemke N, Abbott C, Qualls C, Stromberg S, Canive J, Gasparovic C.
    Schizophr Bull; 2017 May 01; 43(3):611-619. PubMed ID: 27550776
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. In vivo gamma-aminobutyric acid and glutamate levels in people with first-episode schizophrenia: A proton magnetic resonance spectroscopy study.
    Chiu PW, Lui SSY, Hung KSY, Chan RCK, Chan Q, Sham PC, Cheung EFC, Mak HKF.
    Schizophr Res; 2018 Mar 01; 193():295-303. PubMed ID: 28751130
    [Abstract] [Full Text] [Related]

  • 20. Age-related changes in anterior cingulate cortex glutamate in schizophrenia: A (1)H MRS Study at 7 Tesla.
    Brandt AS, Unschuld PG, Pradhan S, Lim IA, Churchill G, Harris AD, Hua J, Barker PB, Ross CA, van Zijl PC, Edden RA, Margolis RL.
    Schizophr Res; 2016 Apr 01; 172(1-3):101-5. PubMed ID: 26925800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.